Dipraglurant
Dyskinesia, Drug-Induced
Addex Pharma S.A.Small moleculePhase 2/3Active
C
38/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 23/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Dyskinesia, Drug-Induced cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MT-5199 Neurocrine Biosciences | Phase 4 | BBB |
Ginkgo Biloba Beijing HuiLongGuan Hospital | Phase 3 | BB |
Varenicline Tartrate Corporal Michael J. Crescenz VA Medical Center | Phase 4 | B |
Safinamide Zambon SpA | Phase 3 | B |
Vitamin B6 Beersheva Mental Health Center | Phase 3 | B |
View all 14 →
Same molecule, other indications
Dipraglurant is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →